Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt's lymphoma cells.
about
Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residuesStructural and Functional Characterization of a Complex between the Acidic Transactivation Domain of EBNA2 and the Tfb1/p62 Subunit of TFIIHEBV gene expression in an NPC-related tumour.Mechanisms that regulate Epstein-Barr virus EBNA-1 gene transcription during restricted latency are conserved among lymphocryptoviruses of Old World primates.Viral response to chemotherapy in endemic burkitt lymphomaBiology and disease associations of Epstein-Barr virus.Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell linesProtein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virusDifferences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cellsHost factors LR1 and Sp1 regulate the Fp promoter of Epstein-Barr virus.Viral latency and its regulation: lessons from the gamma-herpesviruses.Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cellsBurkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferationsGastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein.Clonal Epstein-Barr virus genome in T-cell-rich lymphomas of B or probable B lineageEpstein-Barr virus latent messages with shuffled leader exons: remnants of circumgenomic transcription?Epstein-Barr virus induction of recombinase-activating genes RAG1 and RAG2Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 proteinA simple reverse transcriptase PCR assay to distinguish EBNA1 gene transcripts associated with type I and II latency from those arising during induction of the viral lytic cycleThe Epstein-Barr virus EBNA-1 promoter Qp requires an initiator-like element.Interferon-independent and -induced regulation of Epstein-Barr virus EBNA-1 gene transcription in Burkitt lymphoma.Marked, transient inhibition of expression of the Epstein-Barr virus latent membrane protein gene in Burkitt's lymphoma cell lines by electroporation.Immune regulation in Epstein-Barr virus-associated diseasesEpstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes.The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated.Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes.Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus.Up regulation of the Epstein-Barr virus (EBV)-encoded membrane protein LMP in the Burkitt's lymphoma line Daudi after exposure to n-butyrate and after EBV superinfection.Levels of Epstein-Barr virus DNA in lymphoblastoid cell lines are correlated with frequencies of spontaneous lytic growth but not with levels of expression of EBNA-1, EBNA-2, or latent membrane protein.cis-acting regulatory elements near the Epstein-Barr virus latent-infection membrane protein transcriptional start site.Identification of the Epstein-Barr virus terminal protein gene products in latently infected lymphocytesExpression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo.Host cell-dependent regulation of growth transformation-associated Epstein-Barr virus antigens in somatic cell hybrids.The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle.5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line raelA promoter for the highly spliced EBNA family of RNAs of Epstein-Barr virus.Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines.Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site.
P2860
Q24564697-6CCE1261-5CC0-4273-9FCF-66AA76CF75D2Q24679910-30599A55-331C-4011-9341-3B346778115BQ27682610-7BAFD2A6-266D-4BBD-BFAE-F3204FF6DA8EQ33576708-FCEDCDAF-0D35-4A51-8C01-EB6D45A8F8CDQ33653017-A590CB5B-D1BE-4283-AB93-603353E6F40BQ33767066-2BAE686A-F546-444F-839A-513F9D1591C3Q33772230-77E274B0-B9D8-4924-930F-7B0AFE4846BDQ33784685-8A8A722F-019F-4FC9-9E76-117471CA70D1Q33865166-47830AF4-626B-48C1-A340-0135FB8B2B22Q33929593-ECA56FFF-F547-4E79-83EA-6D1D12F101AFQ33965965-FE6C7786-BA5F-40DB-B139-FDD50CB31D1DQ34039189-0AA98037-2180-4021-9777-F257BCA1F1C9Q34366291-6CD9B02A-6BA1-4479-8267-3FCD26A730DEQ34658852-EFF2140C-6B99-4202-9BED-D889C5454FBFQ35232848-8C30066D-5855-4C1C-9B81-2B2B6AA8136CQ35764932-73653AD5-1A1B-44A0-9F98-C07F619FFF83Q35831215-6CE733EE-107B-4558-900E-EAEB078549A9Q35832348-087A0D07-9935-480C-B6B4-55AC3F3D9D30Q35852995-2A55E4FB-A0C2-456C-BB02-1C47D44B636BQ35854017-4CC469B3-D60E-4695-80F7-53830778E653Q35872919-B96CC698-5CD2-4A12-8AB6-382AE4E97A27Q35874869-7535EBB5-347F-45AF-AF7D-C03ECBCCCA41Q35892261-DECDB814-84A8-4F52-BBCD-AC558F6A304BQ36654123-EC7949D9-11C7-4083-B67E-8C7689D0CAA5Q36669953-21C19908-8038-48C1-82DC-B5A8755DD84FQ36698199-136873B7-561D-4DE7-85E0-F4D4245F836EQ36699468-08B642DA-551A-476D-8E30-FB807620AB59Q36782491-0FA309BC-79DF-4083-89D1-07618BAB4C61Q36791391-5C735677-F1AB-4BE1-9526-ACB0899537F7Q36793368-1B8D0C6F-BA5A-41FE-A3E2-BF20FAE8D9A2Q36799887-224027EF-0411-4C8F-9BB4-219533808835Q36804472-7D3B8100-AD15-41C2-961D-99F0EA5D1AD3Q36807649-FB5EE6D4-BAAE-4246-9631-4F17A76E51AEQ36822172-960EEC8A-AE5B-4B24-9D77-C3A970A66689Q36828590-E0AD6274-C858-42B0-9881-01A52B38FFF4Q36829427-4AB3D82F-AED2-4108-A62B-C93EEAE20AEDQ36829470-5F782765-05BA-45E1-9A36-0361C3B808A7Q36919542-5F8EB74D-DC7D-4A45-B073-8A0A77052D39Q36920279-28F8BED4-F98A-403D-BA31-4B62C34CE799Q37552683-70E89687-069E-4FBD-9568-28B84B1E3B60
P2860
Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt's lymphoma cells.
description
1986 nî lūn-bûn
@nan
1986 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
Restricted expression of EBV l ...... n in Burkitt's lymphoma cells.
@ast
Restricted expression of EBV l ...... n in Burkitt's lymphoma cells.
@en
type
label
Restricted expression of EBV l ...... n in Burkitt's lymphoma cells.
@ast
Restricted expression of EBV l ...... n in Burkitt's lymphoma cells.
@en
prefLabel
Restricted expression of EBV l ...... n in Burkitt's lymphoma cells.
@ast
Restricted expression of EBV l ...... n in Burkitt's lymphoma cells.
@en
P2093
P2860
P1433
P1476
Restricted expression of EBV l ...... n in Burkitt's lymphoma cells.
@en
P2093
P2860
P304
P407
P577
1986-10-01T00:00:00Z